Session Details
[27ISP]Interdisciplinary Session Poster: Antibody therapeutics/Immunology
Mon. Mar 27, 2023 9:00 AM - 5:50 PM JST
Mon. Mar 27, 2023 12:00 AM - 8:50 AM UTC
Mon. Mar 27, 2023 12:00 AM - 8:50 AM UTC
[Room P4] Institute for the Advancement of Higher Education: Main Hall Entrance Bldg. N: 1F
Discussion time: 15:10-15:50
[27ISP-01]The effect of Sapindus mukorossi seed Oil on the treatment of periodontitis: a microbiota analysis
○Haw-Ming Huang1, Shih-Kai Lin1, Kan-Shin Fan2, Sheng-Wei Feng1 (1. Sch. Dent., Taipei Med. Univ., 2. Dent. Dep., En-Chu-Kong Hospit.)
[27ISP-02]A novel method to affect the affinity of ACE2 receptor and spike protein of SARS-CoV-2
○Hsuan-Yu Lai1, Liang-Kai Huang2, Haw-Ming Huang1 (1. Sch. Dent., Taipei Med. Univ., 2. Sch. Biom. Eng., Taipei Med. Univ.)
[27ISP-03]Improving the sensitivity of COVID-19 detective reagent by using nano-diamonds
○Mo-Chiu Hsu1, Li-Fu Chen2, Haw-Ming Huang2 (1. Sch. Biom. Eng., Taipei Med. Univ., 2. Sch. Dent., Taipei Med. Univ.)
[27ISP-04]Inhibition of pulmonary inflammatory response in aspiration pneumonia with S. Mukorossi Hydrosol
○Yi-Fei He1, Haw-Ming Huang1 (1. Sch. Dent., Taipei Med. Univ.)
[27ISP-07]Impedance sensing of whole blood coagulation by an electrochemical method
○Hsuan-Wei Chen1, Hung-Chieh Wu2, Haw-Ming Huang3 (1. Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical Univ., 2. Master program in school of dentistry, Taipei Medical Univ., 3. Graduate Institute of Biomedical Optomechatronics, Taipei Medical Univ.)
[27ISP-08]Functional Characterization of Taiwan Tilapia Hydrolyzed Peptide on Anti-cancer Adjunctive Therapy
○Kuan-Yu Liu1, I-Pei Kuo1,2, Po-Tsang Lee1, Chia-Jung Lee3,4,5 (1. Department of Aquaculture, National Taiwan Ocean Univ., 2. Freshwater Aquaculture Research Center, Fisheries Research Institute, Council of Agriculture, 3. PhD Program in Clinical Drug Development of Herbal Medicine, Taipei Med. Univ., 4. Grad. Inst. Pharm., Taipei Med. Univ., 5. Traditional Herbal Medicine Research Center, Taipei Med. Univ. Hospital)
[27ISP-09 (26P1-am1-007)]Dual functionalization of N-terminus by metal-mediated aldol reaction and Pictet-Spengler reaction
○Kengo Hanaya1, Yuki Morimi1, Kazuaki Taguchi1, Kazuaki Matsumoto1, Shuhei Higashibayashi1, Takeshi Sugai1 (1. Faculty of Pharmacy, Keio University)
[27ISP-10 (26E2-am05)]ADC Therapeutic Window Enhancement Based on the Site-Specific Conjugation Platform: AJICAP® Conjugation
○Rika Takasugi1, Yutaka Matsuda2, Kei Yamada1, Tomohiro Fujii1, Takuya Seki1, Yusuke Iwai1, Akira Chiba1, Tatsuya Okuzumi1 (1. Ajinomoto Co., Inc., 2. Ajinomoto Bio-Pharma Services)
[27ISP-11 (27E2-pm15)]Development of antibody-mimetic HER2-binding small proteins by Smart Design technology
○Tetsuya Kadonosono1, Yutaka Saito2, Ning Lin1, Shinae Kondoh1 (1. Tokyo Tech, 2. AIST)
[27ISP-12 (28P2-am1-017)]Rational Studies for Weak Interaction in Protein thorough the Blue Copper Protein, Pseudoazurin Met16X mutants
○Takamitsu Kohzuma1, Takahide Yamaguchi1, Attila Taborosi1, Seiji Mori1 (1. Grad. Sch. Col. Sci. Engi., Ibaraki Univ.)
[27ISP-13 (26P1-pm2-046)]Automated Sample Preparation For N-linked Glycan Analysis
○Keisuke Fukazawa1, Sachiko Shindo1, Makiko Ichiki1, Futoshi Sato1, Tatsuya Ezaki1 (1. Nihon Waters)
[27ISP-14 (26P1-am1-090)]Preliminary screening of nanobodies for pancreatic cancer theranostics
○Takeshi Fuchigami1, Tsukasa Kosugi1,2, Yusuke Miyanari3, Ayako Tagawa3, Masayuki Munekane1, Kenji Mishiro4, Sakura Yoshida2, Akira Toriba2, Morio Nakayama2, Kazuma Ogawa1,4 (1. Grad. Sch. Pharm., Kanazawa Univ., 2. Grad. Sch. Biomed. Sci., Nagasaki Univ., 3. WPI-NanoLSI, Kanazawa Univ., 4. InFiniti., Kanazawa Univ.)
[27ISP-15 (27C2-pm14)]Development of low-cost antigen detection technology using IgG antibodies from genome-edited chicken
○Takehiro Mukae1, Kyoko Yoshii1, Isao Oishi1 (1. AIST)
[27ISP-16 (26C2-am11)]Anti-CD26 antibody suppresses epithelial-mesenchymal transition on colorectal cancer stem cells
○Takumi Iwasawa1,2, Noriaki Iwao2,3, Kazunori Kato1,4, Chikao Morimoto5 (1. Dept. Biomed. Eng., Grad. Sch. Sci. Eng., Toyo Univ.,, 2. Shizuoka Med. Rese. Center for Disaster., Juntendo Univ., 3. Dept. Hematology, Shizuoka Hosp., Juntendo Univ., 4. Atopy Rese. Center, Juntendo Univ., 5. Dept. of Thera. Develop. & Innova. for Immune Disor. & Cancers, Juntendo Univ.)
[27ISP-17 (26P2-pm2-006)]Oridonin modulates cytotoxic ability of NK cells against Lung cancer cells
○Chuan-Hsin Chang1 (1. Chang Gung University of Science and Technology, Taoyuan 333, Taiwan)
[27ISP-18 (26E5-am13S)]Antibody-dependent cellular cytotoxicity activity of anti-MDA-MB-231 antibody on breast cancer
○Riko Kobayashi1, Rina Kawabata1, Fumiaki Sato1, Yoshinori Kato1, Makoto Tsuiji1, Teruaki Oku1 (1. Hoshi Univ.)
[27ISP-19 (26E5-am14S)]Development and characterization of monoclonal antibody against human TROP2
○Rina Kawabata1, Riko Kobayashi1, Makoto Tsuiji1, Yoshinori Kato1, Teruaki Oku1 (1. Hoshi Univ.)
[27ISP-20 (26P2-pm2-008S)]Effects of high sodium chloride concentration on macrophage-like cell line RAW264.7 cells
○Airi Kubota1, Tomohiro Sato1, Junnosuke Sato1, Teruaki Oku1, Makoto Tsuiji1 (1. Hoshi Univ. Sch. Pharm. & Pharm. Sci.)
[27ISP-21 (26P2-pm2-010S)]Production of a novel monoclonal antibody against human lysophosphatidyl serine receptor-2 (LysoPS2)
○Honoka Fujihira1, Miyako Hoshi1, Kento Takahashi1, Natsuki Kodachi1, Yutaka Tatano2, Takuya Ogawa1, Hideki Yagi1 (1. International University of Health and Welfare, School of Pharmacy , 2. International University of Health and Welfare, School of Pharmacy at Fukuoka)
[27ISP-22 (26P2-pm2-011)]Analysis of CD70-positive IL-13-producing helper T cells in atopic dermatitis model mice
○Aya YOKOTA-NAKATSUMA1, Ka-Min Kim1, Shoko Nagata1, Yoshiharu Ohoka1 (1. Kagawa Sch. Pharm. Sci., Tokushima Bunri Univ.)
[27ISP-23 (26PS2-pm01S)]Structural analysis of fungal chitin in animal serum using functionally-modified human chitotriosidase
○Ren Shimazaki1, Daisuke Yamanaka1, Yoshiyuki Adachi1 (1. Tokyo Univ. Pharm. Life Sci.)
[27ISP-24 (26F3-am05S)]Inflammatory cytokines are synergically induced by coculture of corneal epithelial cells and neutrophil-like cells
○Zirui Zeng1, Yasuhiro Yoshida1 (1. University of Occupational and Environmental Health, Japan.)
[27ISP-25 (26PS3-am12)]Development of brain tumor-accumulating anti-PD-L1 antibody using a detachable PEGylation technology
○Yuki Mochida1, Tao Yang1, Xueying Liu1, Hiroaki Kinoh1, Horacio Cabral2, Kazunori Kataoka1 (1. iCONM, Kawasaki Inst. Ind. Promotion, 2. Grad. Sch. Eng., The Univ. of Tokyo)
[27ISP-26 (27P2-am1-103)]Predicting excipient modulated viscosity of monoclonal antibody formulations
○Yoshirou Kimura1 (1. MOLSIS Inc.)
[27ISP-27 (28PS4-am02)]Risk factors associated with overall survival after carfilzomib in multiple myeloma patients : A retrospective study using a Japanese claims database
○Hiromi Hagiwara1, Takafumi Nakayama2, Hiroya Hashimoto1, Shigeru Kusumoto3, Hidekatsu Fukuta1, Takeshi Kamiya1, Shinsuke Iida3 (1. ncu.clinical trial, 2. ncu.cardiology, 3. ncu.hematology)
[27ISP-28 (28P2-am2-082S)]Production and evaluation of cyclic single-chain antibodies targeting the immune checkpoint molecule PD-1
○Sena Kamesawa1, Mizuki Ogawa1, Shosei Kai2, Yoshiki Funakoshi2, Takashi Sato1, Yoshihiro Kobashigawa1, Hiroshi Morioka1 (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Sch. Pharm. Kumamoto Univ.)
[27ISP-29 (28PS2-am01)]The ‘conformational aging’ of mouse IgG1 observed by MAXS measurement
○Takashi Matsumoto1, Akimi Sato2, Yoshitaka Kameyama2, Takuma Kozono2, Takashi Tonozuka2, Takashi Sato1, Tomokazu Hasegawa1, Hiroyuki Kanda1, Atsushi Nishikawa2 (1. Rigaku Corporation, 2. Graduate School of Agriculture, Tokyo University of Agriculture and Technology)
[27ISP-31 (26P2-am1-118S)]Basic research on the culture method of long-term viable T cells suitable for cancer immunotherapy
- Using in vivo lymphocyte tracing methods -
○Masaki Takeara1, Momoka Osono1, Sayaka Seki1, Yui Shimizu2, Satoshi Hosoya2, Yoshitaka Tanaka2, Hideki Yagi1 (1. International University of Health and Welfare, School of Pharmacy, 2. Nissui Pharmaceutical Co., Ltd.)